Stay updated on Danirixin Safety & Efficacy in Adult Influenza Clinical Trial
Sign up to get notified when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.

Latest updates to the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the funding status notice and Revision: v3.4.1 entry were removed.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page now displays a notice about potential updates due to government funding and directs users to current operating status; the revision version was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded UI label Show glossary and new metadata entries (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with Revision: v3.4.0. Removed the previous entries Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedFooter revision tag updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section was updated with new regional entries (USA and Australia) and old location blocks removed, in Revision: v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedRevision number changed from v3.2.0 to v3.3.2 on the page. This appears to be a minor site maintenance update rather than a modification to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Danirixin Safety & Efficacy in Adult Influenza Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.